up home page bottom

French German version Spanish version Italian version

header image

Monthly Archives: December 2008

Viet Nam Health Ministry Reviews Cervical Cancer Vaccine

The Health Ministry has launched an investigation into the procedures used to approve two cervical cancer vaccines that entered the market this year. The investigation reviews the clinical trials and regulatory approvals made in Viet Nam for the two drugs Gardasil and Cervarix. According to Prof. Nguyen Ba Duc, head of the Cancer Treatment and Prevention Institute in Ha Noi’s K Hospital, the vaccines supposedly protect women for life. But the vaccines have been in circulation for only three years, and the claims had not been conclusively proven, he said

Share

2009 Clinical Trials Predictions and Resolutions

The nation’s ongoing economic turmoil is also threatening the pharmaceutical industry with “unfamiliar challenges,” says Ronald Waife, president of Needham, Mass.-based clinical research consultancy Waife & Associates. Long discovery and product cycles have traditionally shielded pharmaceutical companies from the realities of layoffs and facility shutdowns that they’re now being forced to confront.

Share

Hymen Mystique Remains Intact in Bare-All Culture

Defining Virginity An outbreak in surgeries to restore virginity have spurred Carol Roye, a registered nurse, to talk about what every woman–and every teen in particular–should know about the most fabled part of her reproductive anatomy (WOMENSENEWS)–The hymen is the stuff of legend and lore in many cultures, the treasured prize a woman gives her [...]

Share

Merck Faces Another Tough Year

Merck’s total sales will drop 1% to $23.9 billion next year, according to analyst John Boris at Citigroup. He’s bullish because the stock is so cheap, but in a recent report, he laid out the challenge Merck will face in 2009: Sales of top-seller Singulair, for allergies and asthma, will barely grow because of safety worries, and generics maker Teva Pharmaceuticals (nasdaq: TEVA – news – people ) could launch a copycat ahead of schedule. The company’s vaccines division has stumbled due to manufacturing and marketing issues that executives need to fix–fast.

Share

Cancer Update from Johns Hopkins

After Years Of Telling People Chemotherapy Is The Only Way To Try And Eliminate Cancer…Johns Hopkins Is Finally Starting To Tell You There Is An Alternative Way. 1. Every person has cancer cells in the body. These cancer cells do not show up in the standard tests until they have multiplied to a few billion. [...]

Share

FDA — Progress in Protecting the Food Supply

The following is a FDA Press Release concerning the safety of the nations food supply. It will either cheer you, or chill you. Bottom line— buy locally and in-season foods and a lot of the worry goes away. FOR IMMEDIATE RELEASE December 1, 2008 Media Inquiries: Stephanie Kwisnek, 301-827-0955 Consumer Inquiries: 888-INFO-FDA FDA Reports Significant [...]

Share